Previously, people who were taking smaller doses of GLP-1s were either getting them off label from a physician which means they were prescribed, but not based on the protocols approved by the FDA or getting them illegally online and figuring out how to take them on their own
Understanding Diabetic Acute Kidney Disease and the Role of GLP-1 RAs Diabetic kidney disease (DKD) is a common yet challenging complication of diabetes, often leading to chronic kidney damage, cardiovascular issues, and even end-stage renal disease (ESRD) if left untreated
The molecule on the label may be the same
Pancreatic alpha-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
Mild nausea, reported by a small number of patients after the first one or two injections
The first is that the exact formulation is not published, so if something goes wrong your clinician cannot tell a hospital precisely what was injected